moderna Articles | Developments Today

L’Europe valide le vaccin combiné grippe-COVID de Moderna tandis que les États-Unis prennent du retard

La Commission européenne a autorisé le vaccin combiné à ARNm de Moderna contre la grippe et la COVID, créant le premier produit approuvé de ce type alors que l’injection reste en suspens aux États-Unis.

Key Takeaways

L’Europe a autorisé le vaccin combiné grippe-COVID de Moderna après un avis favorable de l’EMA.
Les données de phase III ont montré des réponses immunitaires plus fortes et aucune préoccupation majeure de sécurité.

DT Editorial AI·Apr 25, 2026·via arstechnica.com

Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot

Moderna and Merck are describing a personalized mRNA cancer treatment as a therapy rather than a vaccine, reflecting how politics and regulation are reshaping biotech language.

Key Takeaways

Moderna and Merck are avoiding the word vaccine for a personalized cancer shot.
The treatment uses mRNA to train the immune system against tumor neoantigens.

DT Editorial AI·Apr 10, 2026·via technologyreview.com

Moderna Pays $950M to Settle COVID Vaccine Patent Fight

Moderna agrees to pay $950 million to settle long-running patent claims with Arbutus and Roivant over lipid nanoparticle technology used in its COVID vaccine.

Key Takeaways

Moderna pays $950M upfront to settle LNP patent dispute
Patents cover lipid nanoparticle tech critical to mRNA vaccine delivery

DT Editorial AI·Mar 5, 2026·4 min read·via endpoints.news

L’Europe valide le vaccin combiné grippe-COVID de Moderna tandis que les États-Unis prennent du retard

Key Takeaways

L’Europe a autorisé le vaccin combiné grippe-COVID de Moderna après un avis favorable de l’EMA.
Les données de phase III ont montré des réponses immunitaires plus fortes et aucune préoccupation majeure de sécurité.

DT Editorial AI·Apr 25, 2026·via arstechnica.com

Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot

Moderna and Merck are describing a personalized mRNA cancer treatment as a therapy rather than a vaccine, reflecting how politics and regulation are reshaping biotech language.

Key Takeaways

Moderna and Merck are avoiding the word vaccine for a personalized cancer shot.
The treatment uses mRNA to train the immune system against tumor neoantigens.

DT Editorial AI·Apr 10, 2026·via technologyreview.com

Moderna Pays $950M to Settle COVID Vaccine Patent Fight

Moderna agrees to pay $950 million to settle long-running patent claims with Arbutus and Roivant over lipid nanoparticle technology used in its COVID vaccine.

Key Takeaways

Moderna pays $950M upfront to settle LNP patent dispute
Patents cover lipid nanoparticle tech critical to mRNA vaccine delivery

DT Editorial AI·Mar 5, 2026·4 min read·via endpoints.news

#moderna

L’Europe valide le vaccin combiné grippe-COVID de Moderna tandis que les États-Unis prennent du retard

Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot

Moderna Pays $950M to Settle COVID Vaccine Patent Fight

L’Europe valide le vaccin combiné grippe-COVID de Moderna tandis que les États-Unis prennent du retard

Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot

Moderna Pays $950M to Settle COVID Vaccine Patent Fight